Home › Funds › ACUTA CAPITAL PARTNERS, LLC › NERV
ACUTA CAPITAL PARTNERS, LLC position in NERV
MINERVA NEUROSCIENCES INC · Health Care
ACUTA CAPITAL PARTNERS, LLC reported holding 709,500 shares of NERV (MINERVA NEUROSCIENCES INC) in its Q2 2026 13F filing — a position valued at US$3.9M, representing 2.74% of its reported portfolio and ranking #14 among its reported holdings. ACUTA CAPITAL PARTNERS, LLC has disclosed NERV holdings in 3 of the last 3 reported quarters, going back to Q4 2025.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How ACUTA CAPITAL PARTNERS, LLC's NERV position evolved
ACUTA CAPITAL PARTNERS, LLC first disclosed a stake in NERV in Q4 2025 at 709,500 shares (US$2.9M). The position peaked in Q1 2026 at 709,500 shares, worth US$4.3M. Across 3 filings, ACUTA CAPITAL PARTNERS, LLC held the position steady without any share-count change. The most recent filing (Q2 2026) shows 709,500 shares valued at US$3.9M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2025 | 709.50K | $2.85M | New |
| Q1 2026 | 709.50K | $4.27M | Hold |
| Q2 2026 | 709.50K | $3.94M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About NERV and 13F data
NERV (MINERVA NEUROSCIENCES INC) is a Health Care company. 56 other funds we track also report a position in NERV — the largest reported positions include Vivo Capital, LLC (US$24.0M), Logos Global Management LP (US$18.3M), Ally Bridge Group (NY) LLC (US$12.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding NERV
- Vivo Capital, LLC 4.32M sh · $23.99M · Q2 2026
- Logos Global Management LP 3.29M sh · $18.25M · Q2 2026
- Ally Bridge Group (NY) LLC 2.18M sh · $12.08M · Q2 2026
- Foresite Capital Management VI LLC 1.99M sh · $11.02M · Q2 2026
- Spruce Street Capital LP 1.66M sh · $9.19M · Q2 2026
- Trails Edge Capital Partners, LP 1.42M sh · $7.88M · Q2 2026
- Seven Fleet Capital Management LP 1.00M sh · $5.56M · Q2 2026
- DV EQUITIES, LLC 754.40K sh · $4.19M · Q2 2026
More on ACUTA CAPITAL PARTNERS, LLC
FAQ
How long has ACUTA CAPITAL PARTNERS, LLC held NERV?
ACUTA CAPITAL PARTNERS, LLC has disclosed NERV holdings in 3 of the last 3 reported quarters, going back to Q4 2025.
What is ACUTA CAPITAL PARTNERS, LLC's current position in NERV?
As of Q2 2026, ACUTA CAPITAL PARTNERS, LLC holds 709.50K shares of NERV (MINERVA NEUROSCIENCES INC), valued at $3.94M, representing 2.74% of its reported portfolio and ranking #14.
Has ACUTA CAPITAL PARTNERS, LLC been buying or selling NERV?
In the latest 13F filing (Q2 2026), ACUTA CAPITAL PARTNERS, LLC held unchanged its position in NERV. The position peaked in Q1 2026 at 709.50K shares.
Which other funds hold NERV?
Other major institutional holders of NERV include Vivo Capital, LLC, Logos Global Management LP, Ally Bridge Group (NY) LLC, among 56 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.